OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 80 filers reported holding OYSTER PT PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,689,000 | +54.1% | 92,500 | 0.0% | 0.02% | +63.6% |
| Q3 2021 | $1,096,000 | -31.1% | 92,500 | 0.0% | 0.01% | -15.4% |
| Q2 2021 | $1,590,000 | -6.0% | 92,500 | 0.0% | 0.01% | -18.8% |
| Q1 2021 | $1,691,000 | -2.9% | 92,500 | 0.0% | 0.02% | -23.8% |
| Q4 2020 | $1,741,000 | -8.4% | 92,500 | +2.8% | 0.02% | -16.0% |
| Q3 2020 | $1,900,000 | -26.9% | 90,000 | 0.0% | 0.02% | -45.7% |
| Q2 2020 | $2,599,000 | +271.3% | 90,000 | +350.0% | 0.05% | +283.3% |
| Q1 2020 | $700,000 | +175.6% | 20,000 | +92.3% | 0.01% | +200.0% |
| Q4 2019 | $254,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
| Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
| NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
| KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
| Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
| COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
| RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
| Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |